Silexion Therapeutics Corp SLXN
Set alert
0.15 USD 0.00 +2.04%
At close · Oct 30
0.15 0.00 +0.62%
After hours · Oct 30, 7:47 PM ET
0.1401 Day range 0.17
0.142 52-week range 33.14
- YTD
- -99.24%
- 1 year
- -99.56%
- Open
- 0.1424
- Prev close
- 0.1423
- Mkt cap
- 2.21M
- Vol
- 741.91K
- Avg vol
- 10.25M
- EPS
- -27.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1401
- High
- 0.17
- Forward P/E
- -3.95
- Beta
- -0.11
- Short ratio
- 0.23
- Inst. own
- 8.15%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.12
- 200-d avg
- 6.82
- 1y target
- 9.00
Financial health
Altman Z-Score
-31.26 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.2×
FY 2020 5y median -0.2× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 1.0×
FY 2020 5y median -0.1× FY 2025
P/FCF -0.2×
FY 2020 5y median -0.4× FY 2025
EV/EBITDA 0.2×
FY 2020 5y median -0.3× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -424.2%
FY 2020 5y median -231.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -457.6%
FY 2020 5y median 30.1% FY 2025
ROIC 250.7%
FY 2020 5y median -49.2% FY 2025
ROA -165.1%
FY 2020 5y median -94.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 192.5%
FY 2020 FY 2025
EPS (diluted) 97.7%
FY 2020 FY 2025
Free Cash Flow -28.6%
FY 2020 FY 2025
Financial Health
Current Ratio 2.4×
FY 2020 5y median 2.3× FY 2025
Quick Ratio 2.4×
FY 2020 5y median 2.3× FY 2025
Debt / Equity 0.2×
FY 2020 5y median -0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2020 5y median 0.5× FY 2025
Interest Coverage 895×
FY 2020 5y median -45.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31